Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07822737 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

PCCT-Defined High-Risk Plaque and Future Coronary Events: The PREDICT Study

Study acronym: PREDICT
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This prospective cohort study aims to determine whether high-risk coronary plaques identified by novel Photon-Counting Detector CT (PCCT) independently predict future major adverse cardiovascular events (MACE). Participants will be followed for MACE and revascularization. The primary hypothesis is that the incidence of MACE is significantly higher in patients with PCCT-defined high-risk plaque than in those without. Additionally, patients will undergo Optical Coherence Tomography (OCT) and angiography within a month after PCCT; PCCT results will be compared with OCT in a cross-sectional analysis, and diagnostic performance will be evaluated against follow-up data.
Trial Details
NCT Number NCT07822737
Lead Sponsor Beijing Chao Yang Hospital
Conditions
(from sponsor)		 Coronary Artery Disease, Plaque, Photon-Counting Computed Tomography
Related terms Coronary Artery Disease, Plaque, Amyloid
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov